Lamotrigine Svus

Lamotrigine, the active ingredient in Lamotrigine Svus, is a sodium channel blocker presented as an oral tablet for oral use. It is employed to manage seizure disorders and to stabilize mood in bipolar disorder, targeting patients diagnosed with epilepsy or bipolar I disorder.

GNH USA supplies Lamotrigine Svus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide, ensuring quality and regulatory compliance across all markets.

Lamotrigine acts on neuronal sodium channels to control abnormal electrical activity in the brain, making it useful for several neurological and psychiatric conditions.

- Epilepsy: reduces the frequency and severity of focal and generalized seizures. - Bipolar disorder: helps prevent recurrence of mood episodes in patients with bipolar I disorder. - Seizure prophylaxis during medication changes: maintains seizure control when other antiepileptic drugs are added or withdrawn.

Lamotrigine is generally well tolerated, but a range of adverse reactions have been reported.

Common Side Effects: - Dizziness: mild to moderate sensation of light‑headedness. - Headache: transient cranial pain. - Nausea: occasional upset stomach. - Rash: mild skin irritation or erythema. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: agranulocytosis or aplastic anemia. - Hepatic failure: signs of liver dysfunction. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe skin reactions: drug reaction with eosinophilia and systemic symptoms (DRESS).

When prescribing or dispensing Lamotrigine, consider the following safety measures.

- Pregnancy: limited data; use only if potential benefit justifies potential risk. - Renal impairment: dose may need adjustment; monitor renal function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant valproate: expect increased lamotrigine plasma levels; avoid high doses. - History of severe skin reactions: avoid use due to risk of recurrence. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Lamotrigine may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising risk of toxicity. - Carbamazepine: significantly reduces lamotrigine concentrations, potentially decreasing seizure control. - Phenytoin: markedly lowers lamotrigine exposure, compromising therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: moderate increase in lamotrigine levels; dose may need adjustment. - Rifampin: moderate decrease in lamotrigine exposure; monitor seizure control. - Serotonergic agents: moderate risk of serotonin syndrome; observe for symptoms.